TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 45 filers reported holding TRINITY BIOTECH PLC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $4,016,000 | -20.0% | 1,003,988 | 0.0% | 0.30% | -12.1% |
Q2 2018 | $5,020,000 | -2.9% | 1,003,988 | 0.0% | 0.35% | -12.2% |
Q1 2018 | $5,171,000 | +1.0% | 1,003,988 | 0.0% | 0.39% | +9.1% |
Q4 2017 | $5,120,000 | +2.3% | 1,003,988 | +12.5% | 0.36% | +9.4% |
Q3 2017 | $5,007,000 | +16.9% | 892,488 | +25.0% | 0.33% | -1.8% |
Q2 2017 | $4,283,000 | +48.6% | 713,822 | +47.6% | 0.34% | +63.1% |
Q1 2017 | $2,882,000 | -9.8% | 483,525 | +4.8% | 0.21% | -9.6% |
Q4 2016 | $3,194,000 | -60.8% | 461,584 | -25.2% | 0.23% | -61.0% |
Q3 2016 | $8,155,000 | +16.6% | 616,846 | 0.0% | 0.58% | +2.1% |
Q2 2016 | $6,995,000 | -2.7% | 616,846 | 0.0% | 0.57% | -5.1% |
Q1 2016 | $7,192,000 | +2.5% | 616,846 | +3.4% | 0.60% | +14.6% |
Q4 2015 | $7,019,000 | +6.4% | 596,846 | +3.5% | 0.53% | +10.9% |
Q3 2015 | $6,599,000 | -33.4% | 576,846 | +5.2% | 0.48% | -23.3% |
Q2 2015 | $9,904,000 | +476.5% | 548,373 | +514.4% | 0.62% | +484.0% |
Q1 2015 | $1,718,000 | +48.1% | 89,255 | +34.8% | 0.11% | +27.7% |
Q4 2014 | $1,160,000 | – | 66,233 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
Centaur Capital | 77,500 | $887,000 | 1.33% |
Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
RK Capital | 565,472 | $6,469,000 | 1.18% |
Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |